Amylyx Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts, with an audacious mission to develop novel therapies for diseases with high unmet medical needs. The company is known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis (ALS) that was approved in Canada as Albrioza in June 2022 and in the United States as Relyvrio in September 2022, though it was withdrawn in April 2024. Amylyx pursues a modality-agnostic approach, advancing a pipeline focused on rare and serious diseases including post-bariatric hypoglycemia and Wolfram syndrome, grounded in rigorous science and mechanistic rationale. Signal Plug searches live against amylyx.com's mail server to find and verify email addresses for any Amylyx Pharmaceuticals, Inc employee.
Signal Plug searches live against amylyx.com's mail server — not a static database. Get a verified email for any Amylyx Pharmaceuticals, Inc employee with confidence score in under 2 seconds.
94% accuracy · No credit card required · 10 free searches/month
Amylyx Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts, with an audacious mission to develop novel therapies for diseases with high unmet medical needs. The company is known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis (ALS) that was approved in Canada as Albrioza in June 2022 and in the United States as Relyvrio in September 2022, though it was withdrawn in April 2024. Amylyx pursues a modality-agnostic approach, advancing a pipeline focused on rare and serious diseases including post-bariatric hypoglycemia and Wolfram syndrome, grounded in rigorous science and mechanistic rationale.
Competitive Advantage
AMX0035/Relyvrio achieved rapid FDA approval for ALS in September 2022 but was withdrawn just 19 months later in April 2024, representing a significant market exit. Amylyx emphasizes rare disease awareness and community engagement, hosting 'Rare Night Out' events during Rare Disease Day celebrations. The company explicitly warns customers about phishing scams impersonating Amylyx, directing authentic communications to the amylyx.com domain only.
The most commonly verified format at Amylyx Pharmaceuticals, Inc:
Medium ConfidenceSignal Plug tests all common patterns against Amylyx Pharmaceuticals, Inc's live mail server and returns whichever passes the SMTP check.
Run a live search for Amylyx Pharmaceuticals, Inc →Data-driven signals to help you prospect Amylyx Pharmaceuticals, Inc effectively.
Amylyx targets patient advocacy groups, rare disease communities, and healthcare providers treating ALS, post-bariatric hypoglycemia, and Wolfram syndrome. The company prioritizes patient-centric recruitment and partnerships with organizations supporting individuals living with high unmet medical needs.
Primary Contact
Neurologists
Tuesday–Thursday, 9am–11am
Signal Plug performs live SMTP verification against amylyx.com's mail server — not a static scraped database — which means results reflect the real, current state of Amylyx Pharmaceuticals, Inc's email infrastructure. Here's how to run a lookup:
Create a free account
Sign up at Signal Plug in under 30 seconds. No credit card required. The Free plan includes 10 searches per month so you can test the tool with real Amylyx Pharmaceuticals, Inc contacts before upgrading.
Enter the contact's name
Type the first and last name of the Amylyx Pharmaceuticals, Inc employee you want to reach. Signal Plug handles all seniority levels, from C-suite to individual contributors.
Enter the domain
Use amylyx.com. Signal Plug tests all common naming patterns automatically and returns only the format that passes the SMTP check.
Get a verified result
Signal Plug returns an email address with a confidence score (0–100) and deliverability status (Valid, Risky, or Catch-all) within 2 seconds. The confidence score tells you how reliable the result is before you use it.
Export and use
One-click CSV export lets you bring Amylyx Pharmaceuticals, Inc contacts into Salesforce, HubSpot, Outreach, Lemlist, or any other tool in your stack. Growth and Scale plan users can run bulk lookups across an entire list of Amylyx Pharmaceuticals, Inc names in a single batch.
Whether you're running outbound sales, recruiting, or building a partnership list, these are the roles most frequently contacted at Biopharmaceutical like Amylyx Pharmaceuticals, Inc.
Based on Amylyx Pharmaceuticals, Inc's profile, the highest-value contacts for outbound are:
Signal Plug works for any role at any seniority level at amylyx.com. If you have a name and the domain, you can find a verified email.
How well Amylyx Pharmaceuticals, Inc fits a typical B2B outbound pipeline, based on available signals.
Good Fit
Funnel Fit Score
Most email finder tools pull from static databases of scraped email addresses. These databases go stale as people change jobs and companies update their email infrastructure. Signal Plug takes a different approach: every search performs a live check against amylyx.com's mail server using SMTP verification. This means results reflect the current state of Amylyx Pharmaceuticals, Inc's email system — not a cached result from months or years ago.
Signal Plug enriches every result with supporting data: a confidence score (0–100), deliverability status (Valid, Risky, or Catch-all), job title where available, and LinkedIn profile URL. This context helps you prioritize which Amylyx Pharmaceuticals, Inc contacts to email first and personalize your outreach before you hit send. Plans start at $29/month for 500 searches — no annual contracts or seat fees.
Signal Plug performs a live SMTP check against amylyx.com's mail server for every query — not a static database lookup. Our platform-wide accuracy rate is 94%. Each result comes with a confidence score (0–100) so you can gauge reliability before using the address.
Free plan: 10 searches. Starter ($29/mo): 500. Growth ($149/mo): 2,000. Scale ($299/mo): 5,000. No company-specific caps.
No. Signal Plug generates and verifies emails in real time via SMTP checks — no static database of Amylyx Pharmaceuticals, Inc employee emails is maintained.
Yes. Growth and Scale plan users can upload a CSV of names and run bulk lookups against amylyx.com in a single batch.
To develop novel therapies for communities with high unmet medical needs, pursuing rigorous science and unwavering commitment to deliver solutions for serious diseases.
Amylyx focuses on amyotrophic lateral sclerosis (ALS), post-bariatric hypoglycemia (PBH), and Wolfram syndrome.
AMX0035 was an experimental ALS therapy approved as Relyvrio in the U.S. (September 2022) and Albrioza in Canada (June 2022), but was withdrawn from the market in April 2024.
Amylyx is headquartered in Cambridge, Massachusetts.
Signal Plug searches in real time against amylyx.com's mail server to find and verify email addresses for Amylyx Pharmaceuticals, Inc employees. Enter a name, enter the domain, get a verified result with a confidence score in under 2 seconds.
Start finding emails free →10 free searches · No credit card required · Upgrade from $29/month